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PURPOSE. The purpose of this study was to quantify the effect of
mitomycin C on rabbit keratocytes, with a view to determining
its potential in modulating corneal stromal wound healing. In
addition, the pathway by which this regulation occurs was
investigated.
METHODS. Keratocytes were isolated from New Zealand White
rabbits and cultured. Hoechst staining and flow cytometric
analyses with annexin V were used to identify the nature of the
keratocyte response to mitomycin C. The response of cultured
keratocytes to 0.005%, 0.01%, 0.02%, 0.04%, and 0.06% mito-
mycin C was evaluated with the lactate dehydrogenase (LDH)
assay. In addition, after exposure of keratocytes to 0.01% mit-
omycin C, the LDH assay was performed at different times of 6,
12, and 24 hours. Keratocytes were preincubated with various
concentrations of CPP32-like protease inhibitor (Z-VAD-FMK),
caspase-8 inhibitor (Z-IETD-FMK), and caspase-9 inhibitor (Z-
LEHD-FMK) and treated with 0.01% mitomycin C. The LDH
assay was performed after 12 hours. Cytochrome c immuno-
stain was performed after exposure to 0.01% mitomycin C.
RESULTS. Hoechst staining revealed shrinkage of the cytoplasm,
formation of apoptotic bodies, and nuclear fragmentation.
Apoptotic changes in cells were detected by flow cytometry.
LDH activities increased significantly at concentrations of
0.005% mitomycin C or greater and were time dependent until
24 hours. Treatment with a CPP32-like protease inhibitor
caused a decrease in LDH activity, although the results were
not statistically significant. Specific inhibitors of caspase-8 and
-9 significantly reduced the LDH activity induced by mitomycin
C. Cytochrome c immunostaining of keratocytes pretreated
with mitomycin C showed strongly positive findings.
CONCLUSIONS. Mitomycin C induced apoptosis, not necrosis, in
cultured corneal keratocytes through the caspase pathway—
specifically, caspase-8 and -9—related to the mitochondrial
pathway. (Invest Ophthalmol Vis Sci. 2003;44:1912–1917)
DOI:10.1167/iovs.02-0977
Apoptosis is a process of natural cell death. Unlike necrosis,apoptosis constitutes an active, physiologic, noninflamma-
tory, and irreversible pathway in a single cell. The apoptosis
system removes individual cells without damaging the sur-
rounding environment. Cells undergoing apoptosis display
membrane blebbing, shrinkage, protein fragmentation, chro-
matin condensation, DNA degradation, and rapid engulfment
of apoptotic cell bodies by neighboring cells, among other
characteristics. There are two major apoptotic pathways in
mammalian cells: One is the death receptor pathway triggered
by members of the death receptor superfamily including CD95.
The other is the mitochondrial pathway, which is activated in
response to extracellular cues and internal insults, such as DNA
damage.1–14
The signals and pathways that trigger apoptosis remain to
be elucidated. Various factors, including viral infection, DNA
damage, cell membrane damage, mitochondrial damage, Fas
ligand, and TNF, induce apoptosis. These pathways are related
to p53, ceramide, CED4, Fas receptor, and cytokine recep-
tor.1–10,14 Mechanical injury and viral infection of corneal
epithelial cells are major factors that trigger the apoptosis of
underlying keratocytes.11–13 Several studies suggest that ker-
atocyte death is mediated by cytokines released by the injured
epithelium.11,14,15 Apoptosis of keratocytes is reportedly an
essential initiator of the wound-healing response that occurs in
the cornea after surgical procedures.12,13 Therefore, control of
this apoptotic pathway may provide a method for regulating
the corneal wound-healing response.
Several studies have demonstrated that mitomycin C is a
powerful modulator of corneal wound healing (Talamo JH, Lee
K, Puliafito CA, Steinert RF, ARVO Abstract 1247, 1991).16
Mitomycin C reduces keratocytes in the anterior stroma after
corneal refractive surgery, leading to a decrease in activated
fibroblasts, production of extracellular matrix, and formation
corneal haze.17–20
Mitomycin C, an alkylating antibiotic agent derived from
Streptomyces caespitosus, blocks DNA and RNA replication
and protein synthesis. The compound is metabolized by liver
enzymes to form an alkylating agent that nonspecifically
crosslinks with DNA in a cell-cycle–dependent manner.21 Mi-
tomycin C inhibits mitosis and the proliferation of capillary and
corneal endothelial cells, corneal epithelial cells, conjunctival
cells, Tenon’s capsule fibroblasts, and other fibroblasts.22–24
In this study, we investigated the effects of mitomycin C on
keratocyte apoptosis in vitro and the specific pathway through
which this cell death occurs.
METHODS
Keratocyte Culture
This study was performed in accordance with the ARVO Statement for
the Use of Animals in Ophthalmic and Vision Research. We obtained
keratocyte primary cultures from New Zealand White rabbit corneas.
Stromal explants were prepared by removing the epithelium and
endothelium and culturing in 10% FBS DMEM at 37°C in 5% CO2, in a
six-well tissue culture plate.
Keratocytes were allowed to migrate from the explant to the
surface of the wells. Cells reached confluence within 15 to 21 days.
These were enzymatically detached with 0.05% trypsin at 37°C for 3
minutes. Suspended keratocytes were centrifuged at 1400 rpm for 5
minutes, and the supernatant was removed. Cells were resuspended in
20 mL medium and cultured in 75-mL flasks at 37°C in 5% CO2 until
confluence was reached. They were then serially trypsinized and pas-
saged three times for use in experiments. Cells were plated at concen-
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trations of 3  103 to 5  103 per well, in 96-well tissue-culture plates.
These were incubated in 1 mL 10% FBS DMEM at 37°C in 5% CO2 for
24 to 48 hours.
Evaluation of Responses Induced by Mitomycin C
Cell Death by Mitomycin C. We evaluated dose-dependent
cell death at 24 hours after application of various concentrations of
mitomycin C (0.005%, 0.01%, 0.02%, 0.04%, and 0.06%). The time
course of cell death was determined after treatment with 0.01% mito-
mycin C at 0, 6, 12, and 24 hours. The lactate dehydrogenase (LDH)
assay (CytoTox 96R Non-Radioactive Cytotoxicity Assay; Promega,
Madison, WI) was used for evaluating cellular damage.2
Identification of the Responses Induced by Mitomycin
C. Hoechst-EthD Staining. Cells were treated with 0.01% mitomy-
cin C for 6 hours, stained with 1 g/mL Hoechst 33342 (Molecular
Probes, Leiden, The Netherlands), and photographed with fluores-
cence and phase-contrast microscopes.
Flow Cytometric Analysis. Keratocytes were either left un-
treated or were treated with 0.01% mitomycin C for 3, 6, and 24 hours.
Cells were incubated (with annexin V FITC, Caltag Laboratories, Bur-
lingame, CA), in buffer containing PI, and analyzed by flow cytometry.3
Analysis of the Apoptotic Pathway. After preincubation of
keratocytes with 0, 10, 100, 1,000 or 10,000 nM CPP32-like protease
inhibitor (Z-VAD-FMK; Calbiochem, Bad Soden, Germany) for 1 hour,
0.01% mitomycin C was added. We evaluated LDH activity after 6
hours. In addition, after preincubation with 0, 50, or 100 M of the
specific caspase-8 inhibitor (LIETD-FMK; Calbiochem) and the
caspase-9 inhibitor (Z-LEHD-FMK; Calbiochem) for 1 hour, cells were
treated with 0.01% mitomycin C, and LDH activity was evaluated after
6 hours.
Cells were immunostained with cytochrome c rabbit polyclonal
antibody (Santa Cruz Biotechnology, Santa Cruz, CA), and apoptotic
changes were observed by phase-contrast microscope.
Statistical Analyses
The ANOVA test was used to evaluate keratocyte apoptosis. Statistical
significance was determined at a P  0.05. Data were analyzed on
computer (SPSS, ver. 10.0 for Windows; SPSS, Inc., Chicago, IL).
RESULTS
Experiments with different concentrations of mitomycin C
revealed that LDH activity was considerably increased at con-
centrations of 0.005% and higher (P  0.01). No significant
differences in activity were noted at concentrations of 0.005%,
0.01%, 0.02%, 0.04%, and 0.06% (Fig. 1A). LDH activity after
treatment with 0.01% mitomycin C was time dependent and
continued to increase until 24 hours (Fig. 1B).
In the group treated with mitomycin C, Hoechst 33342
staining clearly revealed apoptotic characteristics, such as nu-
clear condensation and shrinkage of cytoplasm (Fig. 2). In flow
cytometric analyses of apoptotic cells using annexin V-FITC,
untreated cells (Fig. 3A) were primarily annexin V-FITC and PI
negative, indicating viability and no apoptosis. After treatment
with 0.01% mitomycin C, a significant number of cells were
annexin V-FITC positive and PI negative (Figs. 3B, 3C), signi-
fying that cells were in the early stages of apoptosis, but still
viable. After 24 hours, the cells progressed to a later stage of
apoptosis and stained positively for both PI and annexin V,
indicating nonviability (Fig. 3D).
The CPP32-like inhibitor Z-VAD-FMK did not affect LDH
activity triggered by 0.01% mitomycin C (P  0.05; Fig. 4).
However, LDH activity was significantly decreased by the
caspase-8 inhibitor, IETD-CHO, and the caspase-9 inhibitor,
Z-LEHD-FMK (P  0.03, 0.05, respectively; Figs. 5 and 6).
On immunostaining with cytochrome c, positive findings,
such as a punctate appearance around the cytosol, were
clearly noted in keratocytes (Figs. 7B, 7C) photographed
FIGURE 1. Cell death in rabbit ker-
atocytes caused by mitomycin C ap-
plication was determined by the
LDH assay. Data show mean  SD of
results in three samples at each con-
centration. (A) Dose–dependent cy-
totoxicity of mitomycin C was eval-
uated at 24 hours after application.
LDH activities were significantly in-
creased at the concentration of
0.005% and higher, compared with
the LDH activity without mitomycin
C (P  0.01). (B) Time course of cell
death after application of 0.01% mit-
omycin C. Until 24 hours, LDH activ-
ity was increased. LDH activity
showed a time-dependent course.
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after exposure to 0.01% mitomycin C for 4 (Fig. 7B) or 6
(Fig. 7C) hours.
DISCUSSION
The disappearance of superficial keratocytes after corneal ep-
ithelial injury has been demonstrated in several studies.25–27
This cell loss is mediated by programmed cell death (apopto-
sis)11 related to the release of IL-111 or Fas-ligand14 from the
epithelium and reactive oxygen radicals.29 Keratocytes replen-
ish the anterior stroma within a few days of epithelial injury,
but repopulating keratocytes are in an activated state with dark
nuclei and prominent intracellular organelles. Activated kerato-
cytes are associated with increased collagen deposition and
disorganization, manifesting as haze and regression after refrac-
tive surgical procedures. Transepithelial PRK may cause less
opacity and regression.11,29,30
Recent reports have shown that mitomycin C decreases
corneal opacity after refractive surgery. In clinical trials, mito-
mycin C was applied before PRK. The 9-month follow-up
revealed that the surgically treated corneas remained clear.18
Majmudar et al.31 demonstrated that topical application of
mitomycin C (0.02%) successfully prevented the recurrence of
epithelial fibrosis after debridement. Eight corneas undergoing
mitomycin C treatment after debridement remained clear, with
no recurrence or adverse reaction throughout the follow-up
periods (6–25 months). After the application of mitomycin C
during PRK in rabbit corneas, keratocyte repopulation was not
detected at the anterior stroma.17 Moreover, mitomycin C
inhibited the activation of humane keratocytes and displayed
cytotoxicity to these cells.19
Our Hoechst-EthD staining and annexin V binding assays
demonstrate that cell loss by mitomycin C is due to apoptosis.
Apoptosis in keratocytes induced by mitomycin C occurs in
relation to the mitochondrial pathway. This was confirmed by
FIGURE 2. Micrographs of rabbit
keratocytes exposed to 0.01% mito-
mycin C for 4 (C, D) and 6 (E, F)
hours and control cells (A, B). (A, C,
E) Stained with 1 g/mL Hoechst
33342 and photographed by fluores-
cence microscopy. More fluores-
cence was detected in (C) and (E)
than in (A), (B), (D), and (F). Photo-
graphed by phase-contrast micros-
copy. Apoptotic appearances, such
as nuclear condensation and per-
imembranous vesicles, were clearly
visible (D, F). Magnification, 200.
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the finding that keratocytes treated with mitomycin C were
stained positively for cytochrome c.
Caspase-8 and -9 inhibitors significantly decreased the apo-
ptotic effect of mitomycin C. Although data were not statisti-
cally significant, the diffuse caspase inhibitor, Z-VAD, sup-
pressed apoptosis, consistent with previous studies. Z-VAD
prevented the apoptosis of keratocytes after corneal scraping,
but caused necrosis.32 The compound is therefore not useful
for modulating corneal wound healing. The apoptosis pathway
induced by mitomycin C is related to the caspase pathway, in
particular, caspase-8 and -9. To date, the mechanism of kerato-
cyte apoptosis is unknown. Wilson et al.14 demonstrated that
mRNA coding for several mediators (Bax, BCL-2, BCL-X1, and
ICE) of the common final pathway of apoptosis were ex-
pressed in corneal epithelial, stromal fibroblast, and endothe-
lial cells in primary culture. Elucidation of the pathways and
mediators related to the apoptosis of keratocytes should facil-
itate the control of their cellular behavior.
Our experiments showed that apoptotic responses were
time dependent. Until 6 hours, this response was identified as
apoptosis with Hoechst-EthD staining and annexin V–binding
FIGURE 3. Flow cytometric analysis
of apoptotic cells using annexin V-
FITC. Rabbit cornea keratocytes cells
were left untreated (A) or were
treated for 3 (B), 6 (C), and 24 (D)
hours with 0.01% mitomycin C. Cells
were incubated with annexin V-FITC
in a buffer containing PI and ana-
lyzed by flow cytometry. Untreated
cells were primarily annexin V-FITC
and PI negative (A, bottom left quad-
rant) indicating that the cells were
viable and not undergoing apoptosis.
After treatment with 0.01% mitomy-
cin C, a significant number of cells
are annexin V-FITC positive and PI
negative (B, C, bottom right quad-
rant), indicating that the cells were
in an early stage of apoptosis and still
viable. A population of cells pro-
gressed to a later stage of apoptosis
and stained positively for both PI and
annexin V, indicating that the cells
were no longer viable (D).
FIGURE 4. The effect of a CPP32-like protease inhibitor on kerato-
cytes. Keratocytes were preincubated for 1 hour in various concentra-
tions of CPP32-like inhibitor Z-VAD-FMK. At 12 hours after 0.01%
mitomycin C application, cell toxicity was assayed using the LDH
assay. Data are the mean  SD of results in three samples at each
concentration. LDH activity was somewhat but not significantly re-
duced (P  0.05).
FIGURE 5. The effect of the caspase-8 inhibitor, Z-IETD-FMK. Kerato-
cytes were preincubated for 1 hour in various concentrations of IETD-
CHO. At 12 hours after 0.01% mitomycin C application, cell toxicity
was assayed with the LDH assay. Data are the mean  SD of results in
three samples at each concentration. LDH activity in each group
treated with Z-IETD-FMK was significantly reduced compared with the
control (P  0.03).
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assays. After 24 hours, LDH activity increased significantly.
These responses may have been related to other kinds of
cytotoxicity such as necrosis.33 Therefore, it is important to
determine the optimal duration for application of mitomycin C.
No significant differences in LDH activity were observed at
concentrations greater than 0.005% mitomycin C, signifying
that this concentration was adequate to induce apoptosis in
rabbit keratocytes. This result is evidently not applicable to
human keratocytes, and therefore establishing a safe and effec-
tive concentration and duration of treatment is needed in
humans.
After refractive surgery, apoptotic changes in keratocytes
beneath the surgical wound are an inevitable result of epithe-
lial injury, mechanical ablation by excimer laser, or reactive
oxygen radicals. Although numerous investigations have fo-
cused on inhibiting keratocyte apoptosis to prevent subse-
quent corneal opacity, no promising results have been ob-
tained to date.22,23 Mitomycin C prevented this recruitment
and activation of remnant keratocytes through the induction of
apoptosis in activated keratocytes. We believe that keratocyte
death has different consequences, depending on whether it is
induced in by surgical procedures or occurs in the course of
wound healing.
There are two problems to be solved. One is whether
mitomycin C induces apoptosis only in rapidly proliferative
keratocytes or in inactivated cells as well. In vivo, keratocytes
are surrounded by very compact collagen and are thus inacti-
vated without proliferation or production of excessive colla-
gen. However, in vitro, keratocytes have no inhibitory com-
pact surroundings and may therefore be activated. If
mitomycin C causes apoptosis in both activated and inactivated
cells, the loss of keratocytes may cause corneal thinning years
after a single application. Therefore, the extent and duration of
mitomycin C activity are still to be determined. Although Smith
et al.24 reported that mitomycin C disappears rapidly from the
ocular tissue and that concentration of the chemical is signifi-
cantly reduced by irrigating the tissue afterward, long-term
effects of mitomycin C should be investigated in detail.
The other problem is the evaluation of effective and safe
concentrations of mitomycin C in clinical trials. Sadeghi et al.19
reported inhibitory and cytotoxic concentrations of mitomycin
C in cultured human keratocytes. However, the report was
based on in vitro data and does not reflect the in vivo state.
Corneal haze and refractive regression are two problematic
areas after refractive surgery. Current attention is focused on
modulating the postoperative wound-healing process. Cortico-
steroid and noninflammatory drugs have been investigated for
their potential in regulating stromal haze and refractive regres-
sion. Mitomycin C, which modulates the corneal wound-heal-
FIGURE 6. The effect of the caspase-9 inhibitor, Z-LEHD-FMK. Kerato-
cytes were preincubated for 1 hour in various concentrations of Z-
LEHD-FMK. At 12 hours after 0.01% mitomycin C application, cell
toxicity was determined with the LDH assay. Data are the mean  SD
of results in three samples at each concentration. LDH activity in each
group treated with Z-LEHD-FMK was significantly reduced compared
with the control (P  0.05).
FIGURE 7. Effect of cytochrome c
on mitomycin C–induced apoptosis.
Micrographs of rabbit keratocytes
exposed to 0.01% mitomycin C for 4
(B) or 6 (C) hours and control cells
(A). Cells were stained with cyto-
chrome c and photographed by
phase-contrast microscopy. Apopto-
tic changes such as punctate appear-
ance around the cytosol were clearly
visible (B, C). Magnification, 200.
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ing process, has been investigated for the same purpose. In our
study, mitomycin C induced apoptotic changes through the
caspase cascade related to the mitochondrial pathway in rabbit
keratocytes. This finding is useful for the control of keratocyte
apoptosis and provides an experimental background for appli-
cation of mitomycin C to prevent corneal opacity in refractive
surgery.
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